Kevin G. Connors J. Daniel Cole Geoff Pardo

Geoff has over 14 years of operating and venture experience. He started his career with Arthur D. Little working primarily with companies in Latin America on issues of privatization, operations planning, and strategy development. He subsequently joined Synthes USA as a product manager and led the market introduction of Norian bone graft substitute which was named Synthes’ impact product of the year in 1999. Prior to joining Spray, Geoff worked at Cardinal Partners where he led their investing activity in the medical device sector. He was responsible for sourcing and managing investments in Replication Medical and CardioOptics. Presently, Geoff serves on the Board of Directors at Highgate Orthopedics, Kolis Scientific, Solace Therapeutics, Cascade Ophthalmics, and Facet Solutions. Geoff has a B.A. with honors in History from Brown University and an M.B.A. from the Wharton School of Business.